Disorders of Immune Reactions and Their Immunorehabilitation in Patients with Duodenal Ulcer
Authors
Suleymanov Suleyman Fayzullayevich
Share
Annotation
The immunoreactivity was analyzed in 52 patients with duodenal ulcer (DU) and 36
healthy persons. The suppression of T-system and its subsets, a tension of humoral link of immunity
was observed in patient.
The use traditional method of treatmend was not made a result to disorder of second
immunodificiens in patients with DU.
The usage of Thymoptinum, the dose of which was 1,0 mg – 1,2 mg (in one course) at second
group patients (n=24) with DU cured immune disorder, increased cell immunity, and had
immunocorrесtion and eradication features.
Keywords
Authors
Suleymanov Suleyman Fayzullayevich
Share
References:
1. Belousova I.B. Makarenko V.K. The use of quadruple therapy in Helicobacter pylori infection //
Modern scientific research and innovation. 2014. - No. 11. - Part 3 [Electronic resource]. URL:
http://web. snauka.ru/issues/2014/11/37827 (accessed 09/14/2020) (In Russian).
2. Isaeva G. Sh. Biological properties and virulence // Helicobacter pylori KMAH .– 2018.– Vol. 20,
No. 1. – P. 14–23 (In Russian).
3. Polunina, T. E. Modern therapy of gastric ulcer and duodenal ulcer // Medical Council. – 2011. –
№ 3–4. – С. 82–86. (In Russian).
4. Suleymanov S.F. The use of immunocorrective and eradication therapy in patients with duodenal
ulcer // Journal of Theoretical and Clinical Medicine. – 2018. – No. 4. – pp. 117–118 (In Russian).
5. Suleymanov S.F., Nurilloeva Sh.N., Safarova G.A. Immunocorrective therapy of patients with
duodenal ulcer // Physician's Bulletin. – 2019. – No. 4. – P. 118–120 (In Russian).
6. Suleymanov S. F. Application of Immunotherapy in Patients with the Duodenal Ulcer Deaseases
// LVI Intern. Corres. Sci and Pract. Conf. «International Scientific Review of the Problems and
Prospects of Modern Science and Education» (Boston. USA. March 24-25, 2019). – 2019. – P. 81–83.
7. Suleymanov S.F. Analysis of the degree of immune disorders and the application of
immunocorrectors in deseases of digestive system // European Science Review. – Vienna, Austria.
–2021. – № 9–10. September–October. – P. 12–15.
8. Suleymanov S. F. Use of Immunocorrection and anti–Helicobacter Therapy in Patients with
Duodenal Ulcer // Materials of the ІІІ Scientific and Practical International Distance Conference,
Kharkiv, March 24, 2023. – P. 164–166.
Other articles of the issue
